SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001551163-17-000043
Filing Date
2017-03-31
Accepted
2017-03-31 13:26:32
Documents
29
Period of Report
2016-12-31

Document Format Files

Seq Description Document Type Size
1 prttform10kv2cleansgacomment.htm 10-K 407931
2 prttform10kv2cleansgacomm001.jpg GRAPHIC 49625
3 exhibit31.htm EX-31 7416
4 exhibit32.htm EX-32 3252
  Complete submission text file 0001551163-17-000043.txt   1090025

Data Files

Seq Description Document Type Size
5 prtt-20161231.xml EX-101.INS 101910
6 prtt-20161231.xsd EX-101.SCH 7711
7 prtt-20161231_cal.xml EX-101.CAL 13766
8 prtt-20161231_def.xml EX-101.DEF 12717
9 prtt-20161231_lab.xml EX-101.LAB 63377
10 prtt-20161231_pre.xml EX-101.PRE 49583
Mailing Address 2681 EAST PARLEYS WAY SUITE 204 SALT LAKE CITY UT 84109
Business Address 2681 EAST PARLEYS WAY SUITE 204 SALT LAKE CITY UT 84109 8013223401
PROTECT PHARMACEUTICAL Corp (Filer) CIK: 0001493526 (see all company filings)

IRS No.: 271877179 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-54001 | Film No.: 17729420
SIC: 2834 Pharmaceutical Preparations